What is Leucovorin Calcium?
Leucovorin calcium is a chemically reduced derivative of folic acid. It is used to treat serious blood cell disorders such as thrombocytopenia, neutropenia, anaemia caused by several drugs such as methotrexate, trimethoprim, pyrimethamine, also used to treat patients with colon cancer. It is either given by injection into a vein or a muscle.
Global Leucovorin Calcium Market Outlook
The increasing burden of colorectal cancer and serious blood cell disorder is driving the leucovorin calcium market. Colorectal cancer is the third most commonly diagnosed. The global burden of colorectal cancer is predicted to rise by 60% to more than 2.2 million new cases by 2030. Hemoglobin disorders were prevalent in 60% of 229 countries, potentially affecting 75% of births. About 1.1% of couples globally are at risk of having children with a hemoglobin disorder. Worldwide, over 1% of couples are at risk for hemoglobin disorders, most have at least one affected child, and most affected children die in early childhood.
Increasing approval for a new treatment to propel the leucovorin calcium demand. Shortage of drugs due to manufacturing delays, increased demand limit access to the drug and easy availability of alternative treatment options is hindering the growth of leucovorin calcium market. The market is facing a shortage of drugs due to increased demand, to meet demands manufacturing plants are running at full capacity.
Global Leucovorin Calcium Market
The "Global Leucovorin Calcium Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as Pfizer, Eli Lilly, Hikma Pharmaceuticals, Sagent Pharmaceuticals, Jiangsu Hengrui Medicine. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL LEUCOVORIN CALCIUM MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources
4. GLOBAL LEUCOVORIN CALCIUM MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL LEUCOVORIN CALCIUM MARKET, BY TYPE
5.1. Overview
5.2. Injection
5.3. Tablets
6. GLOBAL LEUCOVORIN CALCIUM MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Online Pharmacies
7. GLOBAL LEUCOVORIN CALCIUM MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
7.5.1. Latin America
7.5.2. Middle East & Africa
8. GLOBAL LEUCOVORIN CALCIUM MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. Pfizer
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Eli Lilly
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Hikma Pharmaceuticals
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. Sagent Pharmaceuticals
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Jiangsu Hengrui Medicine
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
10. Appendix
10.1. Related Reports